SEC Info - Laboratory Corp. of America Holdings

SEC Info℠

Home

Help

Please Sign In

Laboratory Corp. of America Holdings – ‘8-K’ for 9/10/20

On: Thursday, 9/10/20, at 4:14pm ET · For: 9/10/20 · Accession #: 920148-20-49 · File #: 1-11353

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/10/20  Lab Corp. of America Holdings     8-K:7,9     9/10/20   13:222K

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     27K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     16K 
 9: R1          Cover                                               HTML     46K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- lh-20200910_htm                     XML     23K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- lh-20200910_cal                 XML      7K 
 5: EX-101.DEF  XBRL Definitions -- lh-20200910_def                  XML      9K 
 6: EX-101.LAB  XBRL Labels -- lh-20200910_lab                       XML     67K 
 7: EX-101.PRE  XBRL Presentations -- lh-20200910_pre                XML     33K 
 3: EX-101.SCH  XBRL Schema -- lh-20200910                           XSD     11K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    17K 
13: ZIP         XBRL Zipped Folder -- 0000920148-20-000049-xbrl      Zip     16K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

lh-20200910

i 9/10/2020 i 0000920148 i false00009201482020-09-102020-09-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM i 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

i September 10, 2020

(Date of earliest event reported)

i LABORATORY CORPORATION OF AMERICA HOLDINGS

(Exact Name of Registrant as Specified in its Charter)

i Delaware

i 1-11353

i 13-3757370

(State or other jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

i 358 South Main Street

i Burlington,

i North Carolina

i 27215

(Address of principal executive offices)

(Zip Code)

(Registrant’s telephone number including area code) i 336- i 229-1127

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


i ☐			Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act.

Title of Each Class Trading Symbol Name of exchange on which registered

i Common Stock , $0.10 par value i LH i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01			Regulation FD Disclosure

LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Franciscan Missionaries of Our Lady Health System (FMOLHS), announced that they entered into a comprehensive laboratory services relationship that will expand services in Louisiana and Mississippi. LabCorp has acquired FMOLHS' clinical ambulatory laboratory business and select assets and will provide reference testing for all FMOLHS facilities and clinics.


Item 9.01			Financial Statements and Exhibits.

Exhibit			Exhibit Name
Exhibit 99.1			Release dated September 10 , 2020 issued by LabCorp

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABORATORY CORPORATION OF AMERICA HOLDINGS

Registrant

By:

/s/ SANDRA VAN DER VAART

Sandra van der Vaart

Executive Vice President, Chief Legal Officer and Corporate Secretary

i September 10, 2020